Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.
David B. Huang, MD, PhD
Advertisement
Articles by David B. Huang, MD, PhD
Advertisement
Latest Updated Articles
- Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus Vancomycin
Published: December 13th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Is Berberine Nature’s GLP-1?
2
Incidence of Invasive Fungal Infections Following BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma
3
Meeting Patients Where They Are: How Pharmacists Are Helping People Stay on Track With Schizophrenia Treatment
4
New Study Evaluates Neoadjuvant HER3-Targeted ADC in Early Triple-Negative Breast Cancer
5
